Antibiotic Efficacy
Antibiotic Efficacy - Related Videos
02:19
Determining the Antibacterial Efficacy of an Antibiotic-Loaded Polymeric Strip
0 Views •
2025
Source: Sekar, A., et. al., A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials. J. Vis. Exp. (2023)This video demonstrates a luminescence-based assay for assessing the antibacterial efficacy of an antibiotic-loaded polymeric strip by quantifying ATP-driven luminescence, which decreases in bacterial cultures exposed to the antibiotic.
07:46
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
0 Views •
Cited by 159 •
2012
Current diagnostic antimicrobial susceptibility testing relies on the planktonic growth of isolates in nutrient rich, aerobic conditions. Here, we employ an alternative artificial sputum medium to study antimicrobial susceptibility of Pseudomonas aeruginosa biofilms under both aerobic and microaerophilic conditions more representative of the cystic fibrosis lung.
13:39
Antibiotic Susceptibility Testing: Epsilometer Tests to Determine MIC Values of Two Antibiotics and Evaluate Antibiotic Synergy
0 Views •
2023
Source: Anna Bläckberg1, Rolf Lood1 1 Department of Clinical Sciences Lund, Division of Infection Medicine, Biomedical Center, Lund University, 221 00 Lund Sweden Knowledge of the interactions between antibiotics and bacteria is important in understanding how microbes evolve antibiotic resistance. In 1928, Alexander Fleming discovered penicillin, an antibiotic that exerts its antibacterial function by interfering with cell wall regeneration (1). Other antibiotics with diverse mechanisms of...
01:23
Synergistic Antimicrobial Effect of Membrane-Targeting Compounds on Antibiotic-Resistant Bacteria
0 Views •
2026
Take suspensions of an antibiotic-resistant strain of a pathogenic bacterium.Treat one suspension with a short, membrane-disrupting antibiotic compound and the other with both the short compound and a longer, membrane-intercalating compound.Incubate both suspensions with agitation. These compounds mimic the lipid bilayer structure, enabling their spontaneous insertion into bacterial membranes.The short compound spans only part of the membrane’s thickness, creating a structural mismatch. This...
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
0 Views •
Cited by 2 •
2019
We describe a platform that utilizes a library of isogenic antibiotic resistant Escherichia coli for the dereplication of antibiotics. The identity of an antibiotic produced by bacteria or fungi can be deduced by the growth of E. coli expressing its respective resistance gene. This platform is economically effective and time-efficient.
FAQs
Efficacy depends partly on how an antimicrobial interacts with a bacterial target, including cell-wall synthesis, ribosomes, or nucleic-acid replication. These targets represent different cellular processes that can be inhibited, limiting bacterial growth or survival. Comparing responses across drugs helps researchers relate treatment performance to the biological process each drug affects.
A drug’s effect cannot be interpreted independently of dose, exposure, or treatment duration. Antibiotic efficacy is assessed under defined conditions so that differences in bacterial response can be attributed more reliably to the treatment being compared. This approach supports meaningful evaluation of whether a drug inhibits or eliminates susceptible bacteria under the tested regimen.
The same antimicrobial may not perform equally against every bacterial population because pathogen susceptibility influences the response. Measuring growth inhibition or changes in bacterial burden can reveal differences between susceptible and less responsive organisms. Such comparisons help identify resistance and support selection of treatments with activity against the pathogen under investigation.
Host factors form part of the conditions that shape observed treatment performance, alongside the drug, pathogen, dose, exposure, and duration. Consequently, laboratory or infection studies should interpret antimicrobial results in relation to the host context being examined. This is especially relevant in immunology and infection research, where treatment response is evaluated within disease biology.
Common efficacy assessments include growth inhibition, minimum inhibitory concentration, and changes in bacterial burden. Each provides a different readout for comparing antimicrobial treatments or examining pathogen responses. Using these measures under defined testing conditions can help researchers determine whether an intervention suppresses bacterial growth, affects bacterial numbers, or reveals reduced susceptibility.
Researchers use efficacy testing to compare treatments, identify resistance, and evaluate how antimicrobial activity relates to infectious disease management. Results can guide therapy selection and support antimicrobial stewardship by distinguishing treatments with stronger activity under defined conditions. The same evidence also contributes to developing interventions intended to improve control of bacterial infection.